Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Extra Virgin Olive Oil (EVOO) Supplementation on Serum COX-2, Malondialdehyde, TNF-alpha, and Hand-Foot Syndrome Incidence in Patients With Capecitabine

NCT06188000 is registered in ClinicalTrials.gov with Universitas Sriwijaya as lead sponsor.

NCT NCT06188000
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06188000 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Extra Virgin Olive Oil (EVOO) Supplementation on Serum COX-2, Malondialdehyde, TNF-alpha, and Hand-Foot Syndrome Incidence in Patients With Capecitabine
Lead sponsor
Universitas Sriwijaya
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2023
Completion date
February 20, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

capecitabine, hand and foot skin reaction, hand and foot syndrome